Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Published:2016-12 Issue:5 Volume:2 Page:553-561
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Novara Giacomo,Giannarini Gianluca,Alcaraz Antonio,Cózar-Olmo José-M.,Descazeaud Aurelien,Montorsi Francesco,Ficarra Vincenzo

Publisher

Elsevier BV

Subject

Urology

Reference36 articles.

1. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;Oelke;Eur Urol,2013

2. Update on AUA guideline on the management of benign prostatic hyperplasia;McVary;J Urol,2011

3. A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines;Cornu;Eur Urol,2010

4. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in France: a comprehensive population study;Lukacs;Eur Uro,2013

5. Serenoa repens: the scientific basis for the treatment of benign prostatic hyperplasia;Habib;Eur Urol Suppl,2009

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serenoa repens for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement: An Updated Cochrane Review;The World Journal of Men's Health;2024

2. Natural Products in the Treatment of Lower Urinary Tract Dysfunction and Infection;Handbook of Experimental Pharmacology;2024

3. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms;European Urology;2023-08

4. Overview of current pharmacotherapeutic options in benign prostatic hyperplasia;Expert Opinion on Pharmacotherapy;2023-07-21

5. Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports;Phytotherapy Research;2023-07-18